Mirabella Financial Services LLP Protalix Bio Therapeutics, Inc. Transaction History
Mirabella Financial Services LLP
- $2.33 Billion
- Q1 2025
A detailed history of Mirabella Financial Services LLP transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Mirabella Financial Services LLP holds 30,000 shares of PLX stock, worth $45,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$45,000% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
69Shares Held
8.07MCall Options Held
227KPut Options Held
54.5K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.19MShares$1.78 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny963KShares$1.44 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA859KShares$1.29 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL685KShares$1.03 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0615KShares$922,6270.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $74.6M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...